Replies to post #246031 on Anavex Life Sciences Corp (AVXL)

[JWC3]

Someone apparently is not aware that AVXL has 8 clinical trials currently ongoing. One of these, the PDD trial designed by the Michael J Fox Foundation, was more than completely enrolled. That was announced on January 27, 2020. Possibly the completed enrollment could be actually 2 weeks earlier than the announcement. The PDD dosing is 14 weeks, so 14 weeks after January 27, 2020 is May 4, 2020. So the dosing completion of PDD can occur 2 weeks prior to that! Hence the April 20 date is the first possible date that the results of the PDD trial can be published. Some things will be available rather quickly and may be legally revealed.